.custom-subheader { font-family: Roboto, "Helvetica Neue", Helvetica, Arial, sans-serif; font-size: 17px; font-weight: 600; line-height: 1.5em; margin-top: 1.5em; margin-bottom: 1em; }
Skip to main content
Displaying 169 of 2939 articles.
Results presented at Conference on Retroviruses and Opportunistic Infections show that two broadly neutralizing antibodies can keep HIV suppressed for months.

New imaging reveals a built-in safeguard that allows B cell populations to rapidly expand in germinal centers without introducing deleterious mutations.

New study demonstrates how high-affinity B cells "bank" their best traits instead of rolling the dice and risking deleterious mutations, with implications for better vaccine design.

Jeffrey M. Friedman’s lab has discovered a mechanism to explain how leptin resistance works.

New insights could fine-tune this immunotherapy to avoid a common side effect without sacrificing efficacy.

It acts as a sort of molecular fumigator to battle phages and plasmids.

An autoimmune condition makes certain people much more susceptible to West Nile virus and many other severe viral diseases. In the future, a screening process could reveal if you’re at risk.  

New findings on how past viral respiratory infections affect future, unrelated ones could lead to therapies for boosting general antiviral immunity—and potentially better pandemic preparedness.

The study explains why treatments for many autoimmune and inflammatory diseases raise the risk of contracting TB—and also upends long-held assumptions about what kicks off an immune response.      

New understanding of how the virus replicates could lead to new therapeutic targets for HBV.
View
View